Auto-titrating oral appliance for sleep disordered breathing

Ended Project Grant Awarded Last action

Award ID
R43HL166039
Recipient
Awarding agency
Obligated
$876,594

Award facts

Assistance listing
93.837 Cardiovascular Diseases Research
Completion date
Originally
Place of performance
Minnesota, USA

Award details come from USAspending.gov.

Description

As the agency reported it.

Abstract
Rush river research corp. (RRR) proposes to develop an auto-titrating oral appliance that fits fully-in-the-mouth for sleep disordered breathing (SDB) therapy. SDB, resulting from airway obstruction, is directly linked to the four most costly diseases in the united states: heart disease, diabetes, obesity, and cancer. Research has shown that SBD sufferers are three times more likely to DIE prematurely. Current therapeutic devices, such as cpap, surgery, and traditional non-auto-titrating oral appliances are the most common therapy approaches to SBD, with cpap being considered the gold standard. Despite 30 years of cpap commercialization, 90% of the potential U.S. And worldwide markets for SDB therapy remain untreated. Lack of toleration of cpap leads to poor compliance among users. Oral mandibular advancement appliances typically provided, fit, and titrated by dentists are often an alternative for patients with unsuccessful experiences with cpap or with mild SDB. However, the titration process can require multiple visits to the dentist over several months and the dentists lack feedback on compliance and efficacy during and after titration. Inflammation of the temporomandibular joint (TMJ) resulting from the fixed and continuous artificial advancement of the mandible can also occur. The proposed connected auto-titrating, SDB sensing, oral appliance can mitigate issues with the titration process and be optimized to provide minimum therapy necessary to improve user safety and comfort. RRR and collaborators propose to show feasibility of a fully-in-the-mouth micro manipulating oral appliance by developing a prototype appliance and demonstrating functionality in an overnight human study of people suffering from SDB. RRR has assembled a highly qualified team of sleep and oral medicine experts and experienced medical device designers to achieve these goals.

Transactions

Action Obligated Date
Amendment $0
Amendment $0
Amendment $21,168
Amendment $21,168
Amendment $278,086
Amendment $278,086
Original award $278,086

Subawards

Subrecipient Amount Awarded
The Trustees Of The University Of Pennsylvania Assess the feasibility, safety, and effectiveness of a fully intraoral appliance for treatment of snoring and mild to moderate sleep apnea. The project includes… $74,462

Quick answers

Who received award R43HL166039?

R43HL166039 was awarded to Rush River Research Corporation by National Heart Lung and Blood Institute (National Institutes of Health) on September 1, 2023.

How much is award R43HL166039 worth?

$876,594 has been obligated on R43HL166039.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login